Press Release: Oblong Announces Financial Results for First Quarter 2025 and Provides Business Update

Dow Jones
13 May

Oblong Announces Financial Results for First Quarter 2025 and Provides Business Update

DENVER--(BUSINESS WIRE)--May 13, 2025-- 

Oblong, Inc. (Nasdaq: OBLG) ("Oblong" or the "Company"), today reported financial results for the three months ended March 31, 2025, and provided updates on the Company's business and strategy.

"As of March 31, 2025, we're in a very strong financial position with $4.3 million in cash, zero debt, and a fresh $518,000 boost from warrant exercises in April 2025. This war chest gives us the firepower to drive our strategy into late 2026. We're aggressively pursuing high-growth M&A opportunities, zeroing in on recurring revenue models, digital currency and AI-driven innovators that can supercharge profitability and operating efficiency. In a dynamic market, our disciplined approach ensures we're primed to pounce on the right deals--targets that could fuel innovation, unlock value, and deliver outsized returns for our shareholders," said Peter Holst, CEO of Oblong.

First Quarter 2025 Financial Results

   -- As of March 31, 2025, the Company had $4.3 million in cash and cash 
      equivalents and no debt. 
 
   -- Subsequent to the end of the first quarter of 2025, the Company raised 
      net cash proceeds of $0.5 million from common stock warrant exercises. 
 
   -- Total revenue was $0.6 million for the first quarter of both 2025 and 
      2024. 
 
   -- Net loss was $0.7 million for the first quarter of 2025 compared to $1.1 
      million for the first quarter of 2024. 
 
   -- Adjusted EBITDA ("AEBITDA") loss was $0.7 million for the first quarter 
      of 2025 compared to $1.2 million for the first quarter of 2024. AEBITDA 
      loss is a non-GAAP financial measure. See "Non-GAAP Financial 
      Information" below for additional information regarding this non-GAAP 
      financial measure, and "GAAP to Non-GAAP Reconciliation" for a 
      reconciliation of this non-GAAP financial measure to net loss. 

Non-GAAP Financial Information

Adjusted EBITDA ("AEBITDA") loss, a non-GAAP financial measure, is defined as net loss before stock-based compensation, income tax expense, and interest income, net. AEBITDA loss is not intended to replace operating loss, net loss, cash flow, or other measures of financial performance reported in accordance with generally accepted accounting principles (GAAP). Rather, AEBITDA loss is an important measure used by management to assess the operating performance of the Company and to compare such performance between periods. AEBITDA loss as defined here may not be comparable to similarly titled measures reported by other companies due to differences in accounting policies. Therefore, AEBITDA loss should be considered in conjunction with net loss and other performance measures prepared in accordance with GAAP, such as operating loss or cash flow used in operating activities and should not be considered in isolation or as a substitute for GAAP measures, such as net loss, operating loss or any other GAAP measure of liquidity or financial performance. A GAAP to non-GAAP reconciliation of net loss to AEBITDA loss is shown under "GAAP to Non-GAAP Reconciliation" later in this release.

About Oblong, Inc.

Oblong (Nasdaq:OBLG) provides innovative and patented technologies that change how people work, create, and communicate. Oblong's product, Mezzanine$(TM)$, is a meeting technology platform that offers simultaneous content sharing to achieve situational awareness for both in-room and remote collaborators. Oblong supplies Mezzanine systems to Fortune 500 and enterprise customers. For more information, visit www.oblong.com and Oblong's Twitter and Facebook pages.

Forward-looking and cautionary statements

This press release and any oral statements made regarding the subject of this release contain forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, that address activities that Oblong assumes, plans, expects, believes, intends, projects, estimates, or anticipates (and other similar expressions) will, should, or may occur in the future are forward-looking statements. Oblong's actual results may differ materially from its expectations, estimates, and projections, and consequently, you should not rely on these forward-looking statements as predictions of future events. Without limiting the generality of the foregoing, forward-looking statements contained in this press release include statements relating to (i) the Company's pursuit of mergers and acquisitions (M&A), including the Company's goal to identify high-potential targets that align with our vision for innovation and value creation, and (ii) the Company's liquidity projections. There can be no assurance that the Company's M&A strategy will result in a merger, sale, or other business combination involving the Company. The forward-looking statements are based on management's current belief, based on currently available information, as to the outcome and timing of future events, and involve factors, risks, and uncertainties, including the volatility of market price for our securities, that may cause actual results in future periods to differ materially from such statements. A list and description of these and other risk factors can be found in the Company's Annual Report on Form 10-K for the year ending December 31, 2024, and in other filings made by the Company with the SEC from time to time. Any of these factors could cause Oblong's actual results and plans to differ materially from those in the forward-looking statements. Therefore, the Company can give no assurance that its future results will be as estimated. The Company does not intend to, and disclaims any obligation to, correct, update, or revise any information contained herein.

 
 
                              OBLONG, INC. 
                 CONDENSED CONSOLIDATED BALANCE SHEETS 
      ($ in thousands, except shares, par value, and stated value) 
 
                                 March 31, 2025      December 31, 2024 
                                ----------------   --------------------- 
ASSETS                            (unaudited) 
Current assets: 
   Cash and cash equivalents     $         4,316    $           4,965 
   Accounts receivable, net                  113                  186 
   Prepaid expenses and other 
    current assets                           321                  118 
                                    ------------       -------------- 
      Total current assets                 4,750                5,269 
   Other assets                                5                    6 
                                    ------------       -------------- 
      Total assets               $         4,755    $           5,275 
                                    ============       ============== 
LIABILITIES AND STOCKHOLDERS' 
EQUITY 
Current liabilities: 
   Accounts payable                           70                  105 
   Accrued expenses and other 
    current liabilities                    1,294                1,131 
   Deferred revenue                           41                   36 
                                    ------------       -------------- 
      Total current 
       liabilities                         1,405                1,272 
      Total liabilities                    1,405                1,272 
                                    ------------       -------------- 
Commitments and contingencies 
(see Note 8) 
Stockholders' equity: 
   Preferred stock Series F, 
   convertible; $0.0001 par 
   value; $586,450 stated 
   value; 5,000,000 shares 
   authorized, 545 shares 
   issued and outstanding as 
   of March 31, 2025, and 
   December 31, 2024                          --                   -- 
   Common stock; $0.0001 par 
   value; 150,000,000 shares 
   authorized, 1,154,926 and 
   1,154,737 shares issued 
   and outstanding as of 
   March 31, 2025, 
   respectively, and 
   1,144,926 and 1,144,737 
   shares issued and 
   outstanding as of December 
   31, 2024, respectively                     --                   -- 
   Treasury stock, 189 common 
    shares                                  (181)                (181) 
   Additional paid-in capital            236,477              236,458 
   Accumulated deficit                  (232,946)            (232,274) 
                                    ------------       -------------- 
      Total stockholders' 
       equity                              3,350                4,003 
                                    ------------       -------------- 
      Total liabilities and 
       stockholders' equity                4,755                5,275 
                                    ============       ============== 
 
 
 
                         OBLONG, INC. 
       CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
                 ($ in thousands) (Unaudited) 
 
                                         Three Months Ended 
                                             March 31, 
                                      ------------------------ 
                                           2025      2024 
                                      ---  -----    ------- 
Revenue                                 $    622   $    626 
Cost of revenue                              373        629 
                                      ---  -----    ------- 
Gross profit                                 249         (3) 
Operating expenses: 
   Research and development                    3         50 
   Sales and marketing                         8         54 
   General and administrative                929      1,077 
                                      ---  -----    ------- 
Total operating expenses                     940      1,181 
                                      ---  -----    ------- 
Operating loss                              (691)    (1,184) 
                                      ---  -----    ------- 
   Interest income, net                      (26)       (48) 
Loss before income taxes                    (665)    (1,136) 
   Income tax expense                          7         -- 
                                      ---  -----    ------- 
Net loss                                $   (672)  $ (1,136) 
                                      ===  =====    ======= 
 
 
GAAP to Non-GAAP Reconciliation: 
---------------------------------------------------- 
                               Three Months Ended 
                                   March 31, 
                            ------------------------ 
                                 2025      2024 
                                ------    ------- 
Net loss                     $    (672)  $ (1,136) 
Interest income, net               (26)       (48) 
Income tax expense                   7         -- 
Stock-based compensation            --         31 
                                ------    ------- 
Adjusted EBITDA loss         $    (691)  $ (1,153) 
                                ======    ======= 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250513133746/en/

 
    CONTACT:    Investor Relations Contact 

David Clark

investors@oblong.com

(213) 683-8863 ext. 5

 
 

(END) Dow Jones Newswires

May 13, 2025 08:30 ET (12:30 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10